German Pharmaceuticals & Biotech Potentially Undervalued Companies

Ardelyx

Market Cap: €1.5b

Ardelyx, Inc. discovers, develops, and commercializes medicines to treat unmet medical needs in the United States and internationally.

Grifols

Market Cap: €7.2b

Operates as a plasma therapeutic company in Spain, the United States, Canada, and internationally.

Gilead Sciences

Market Cap: €137.6b

A biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally.

Vanda Pharmaceuticals

Market Cap: €263.5m

A biopharmaceutical company, focuses on the development and commercialization of therapies to address high unmet medical needs worldwide.

Siegfried Holding

Market Cap: €3.8b

Engages in contract development and manufacturing of active pharmaceutical ingredient (API) and finished dosage forms worldwide.

Ipsen

Market Cap: €9.5b

Operates as a biopharmaceutical company worldwide.

Innoviva

Market Cap: €1.2b

Engages in the development and commercialization of pharmaceutical products in the United States and internationally.

Ocular Therapeutix

Market Cap: €2.2b

A biopharmaceutical company, engages in the development and commercialization of therapies for retinal diseases and other eye conditions using its bioresorbable hydrogel-based formulation technology in the United States.

BeOne Medicines

Market Cap: €36.0b

An oncology company, engages in discovering and developing various treatments for cancer patients in the United States, China, Europe, and internationally.

Viridian Therapeutics

Market Cap: €1.5b

Engages in discovering, developing, and commercializing treatments for serious and rare diseases.

MaaT Pharma

Market Cap: €66.8m

A late-stage clinical company, engages in the development of gut microbiome-driven therapies to modulate the immune system and improve cancer survival.

Recordati Industria Chimica e Farmaceutica

Market Cap: €10.9b

Researches, develops, produces, and sells pharmaceuticals in Italy, the United States, Spain, France, Germany, Russia, Ukraine, Turkey, Portugal, North Africa, and internationally.

WuXi Biologics (Cayman)

Market Cap: €159.4b

An investment holding company, provides end-to-end solutions and services for biologics discovery, development, and manufacturing for biologics industry in the People’s Republic of China, North America, Europe, Singapore, Japan, South Korea, and Australia.

Veru

Market Cap: €50.1m

A late clinical stage biopharmaceutical company, focuses on developing medicines for treatment of metabolic diseases, oncology, and viral-induced acute respiratory distress syndrome (ARDS).

Organigram Global

Market Cap: €327.8m

Engages in the production and sale of cannabis and cannabis-derived products in Canada.

1CM

Market Cap: €45.9m

Operates as a multi-jurisdictional cannabis company in Canada.

Novavax

Market Cap: €1.4b

A biotechnology company, engages in the discovering, developing, and commercializing vaccines to protect against serious infectious diseases in the United States, Europe, and internationally.

NewAmsterdam Pharma

Market Cap: €2.8b

A late-stage biopharmaceutical company, develops therapies to enhance patient care in populations with metabolic disease.

Acrux

Market Cap: €5.7m

Develops and commercializes generic and topically applied pharmaceutical products in Australia, Europe, the United States, and internationally.

Bavarian Nordic

Market Cap: €18.1b

Develops, manufactures, and supplies life-saving vaccines.

Haleon

Market Cap: €30.6b

Engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific.

Pacific Biosciences of California

Market Cap: €369.5m

Designs, develops, and manufactures sequencing solution to resolve genetically complex problems.

Sangui Biotech International

Market Cap: €419.8k

Through its subsidiaries, engages in the manufacturing and sales of wound treatment and cosmetic products.

Bausch Health Companies

Market Cap: €2.5b

Operates as a diversified specialty pharmaceutical and medical device company, develops, manufactures, and markets a range of products primarily in gastroenterology, hepatology, neurology, dermatology, generic pharmaceuticals, over-the-counter (OTC) products, aesthetic medical devices, and eye health in the United States and internationally.

Diaceutics

Market Cap: €125.2m

A diagnostic commercialization company, provides data, data analytics, and implementation services for pharma and biotech companies.

Elanco Animal Health

Market Cap: €9.3b

An animal health company, innovates, develops, manufactures, and markets products for pets and farm animals worldwide.

Vireo Growth

Market Cap: €617.4m

Operates as a cannabis company that cultivates, manufactures, processes, and distributes medical and adult-use cannabis products in Maryland, Minnesota, and New York.

Shanghai Junshi Biosciences

Market Cap: €46.6b

A biopharmaceutical company, engages in the discovery, development, and commercialization of various drugs in the therapeutic areas of malignant tumors, neurological, autoimmune, chronic metabolic, nervous system, and infectious diseases in the People's Republic of China.

Niagen Bioscience

Market Cap: €758.4m

Operates as a bioscience company engages in developing healthy aging products.

Repligen

Market Cap: €6.7b

A life sciences company, develops and commercializes bioprocessing technologies and systems in North America, Europe, the Asia Pacific, and internationally.

Crinetics Pharmaceuticals

Market Cap: €3.2b

A clinical-stage pharmaceutical company, focuses on the discovery, development, and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors.

Tilray Brands

Market Cap: €1.4b

A lifestyle consumer products company, engages in the research, cultivation, processing, and distribution of medical cannabis products in Canada, the United States, Europe, the Middle East, Africa, and internationally.

BioLife Solutions

Market Cap: €1.2b

Develops, manufactures, and markets bioproduction products and services for the cell and gene therapy (CGT) industry in the United States, Europe, the Middle East, Africa, and internationally.

Astellas Pharma

Market Cap: €3.0t

Manufactures, markets, and imports and exports pharmaceuticals in Japan and internationally.

Fine Foods & Pharmaceuticals N.T.M

Market Cap: €217.1m

Fine Foods & Pharmaceuticals N.T.M. S.p.A.

Ipsen

Market Cap: €9.5b

Operates as a biopharmaceutical company worldwide.